Plain-English translation of NCT07427940 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is collecting cells from children who have been diagnosed with autism spectrum disorder. Researchers will reprogram these cells into special stem cells in the laboratory, which allows them to study what's different about cells from people with autism and look for clues about what causes the condition.
Autism is a complex condition that likely involves many different biological pathways. By studying cells from carefully evaluated patients, researchers hope to understand which specific cellular problems are linked to autism and lay the groundwork for developing better treatments.
You would have a blood sample collected, which doctors will use to obtain cells for the study. Researchers will reprogram these cells into stem cells and perform detailed laboratory tests to understand their characteristics. Your participation helps build a valuable library of cell models that scientists around the world can study to better understand autism.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Italy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Enrollment target
~100 participants
Started
August 2024
Primary completion
August 2026
Age range
3 Years – 15 Years
Last updated on clinicaltrials.gov in November 2026.